Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing β-like cells

Maria Joao Lima, Kenneth R. Muir, Hilary M. Docherty, Robert Drummond, Neil W.A. McGowan, Yves Heremans, Shareen Forbes, Isabelle Houbracken, James A. Ross, Stuart J. Forbes, Philippe Ravassard, Harry Heimberg, John Casey, Kevin Docherty

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Because of the lack of tissue available for islet transplantation, new sources of β-cells have been sought for the treatment of type 1 diabetes. The aim of this study was to determine whether the human exocrine-enriched fraction from the islet isolation procedure could be reprogrammed to provide additional islet tissue for transplantation. The exocrine-enriched cells rapidly dedifferentiated in culture and grew as a mesenchymal monolayer. Genetic lineage tracing confirmed that these mesenchymal cells arose, in part, through a process of epithelial-to-mesenchymal transitioning (EMT). A protocol was developed whereby transduction of these mesenchymal cells with adenoviruses containing Pdx1, Ngn3, MafA, and Pax4 generated a population of cells that were enriched in glucagon-secreting α-like cells. Transdifferentiation or reprogramming toward insulin-secreting β-cells was enhanced, however, when using unpassaged cells in combination with inhibition of EMT by inclusion of Rho-associated kinase (ROCK) and transforming growth factor-β1 inhibitors. Resultant cells were able to secrete insulin in response to glucose and on transplantation were able to normalize blood glucose levels in streptozotocin diabetic NOD/SCID mice. In conclusion, reprogramming of human exocrine-enriched tissue can be best achieved using fresh material under conditions whereby EMT is inhibited, rather than allowing the culture to expand as a mesenchymal monolayer.
Original languageEnglish
Pages (from-to) 2821-2833
Number of pages13
JournalDiabetes
Volume62
Issue number8
Early online date22 Apr 2013
DOIs
Publication statusPublished - Aug 2013

Fingerprint

Insulin
Islets of Langerhans Transplantation
Glucagon-Secreting Cells
Tissue Transplantation
rho-Associated Kinases
Inbred NOD Mouse
SCID Mice
Insulin-Secreting Cells
Transforming Growth Factors
Streptozocin
Type 1 Diabetes Mellitus
Adenoviridae
Blood Glucose
Transplantation
Glucose
Population
Therapeutics

Keywords

  • islet transplantation
  • stem cells
  • pancreatic transcription factors
  • gene therapy

Cite this

Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing β-like cells. / Lima, Maria Joao; Muir, Kenneth R. ; Docherty, Hilary M. ; Drummond, Robert; McGowan, Neil W.A. ; Heremans, Yves; Forbes, Shareen; Houbracken, Isabelle; Ross, James A. ; Forbes, Stuart J. ; Ravassard, Philippe; Heimberg, Harry; Casey, John; Docherty, Kevin.

In: Diabetes, Vol. 62, No. 8, 08.2013, p. 2821-2833 .

Research output: Contribution to journalArticle

Lima, MJ, Muir, KR, Docherty, HM, Drummond, R, McGowan, NWA, Heremans, Y, Forbes, S, Houbracken, I, Ross, JA, Forbes, SJ, Ravassard, P, Heimberg, H, Casey, J & Docherty, K 2013, 'Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing β-like cells', Diabetes, vol. 62, no. 8, pp. 2821-2833 . https://doi.org/10.2337/db12-1256
Lima, Maria Joao ; Muir, Kenneth R. ; Docherty, Hilary M. ; Drummond, Robert ; McGowan, Neil W.A. ; Heremans, Yves ; Forbes, Shareen ; Houbracken, Isabelle ; Ross, James A. ; Forbes, Stuart J. ; Ravassard, Philippe ; Heimberg, Harry ; Casey, John ; Docherty, Kevin. / Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing β-like cells. In: Diabetes. 2013 ; Vol. 62, No. 8. pp. 2821-2833 .
@article{90b4db76fa884bf9a7a67784a05e6229,
title = "Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing β-like cells",
abstract = "Because of the lack of tissue available for islet transplantation, new sources of β-cells have been sought for the treatment of type 1 diabetes. The aim of this study was to determine whether the human exocrine-enriched fraction from the islet isolation procedure could be reprogrammed to provide additional islet tissue for transplantation. The exocrine-enriched cells rapidly dedifferentiated in culture and grew as a mesenchymal monolayer. Genetic lineage tracing confirmed that these mesenchymal cells arose, in part, through a process of epithelial-to-mesenchymal transitioning (EMT). A protocol was developed whereby transduction of these mesenchymal cells with adenoviruses containing Pdx1, Ngn3, MafA, and Pax4 generated a population of cells that were enriched in glucagon-secreting α-like cells. Transdifferentiation or reprogramming toward insulin-secreting β-cells was enhanced, however, when using unpassaged cells in combination with inhibition of EMT by inclusion of Rho-associated kinase (ROCK) and transforming growth factor-β1 inhibitors. Resultant cells were able to secrete insulin in response to glucose and on transplantation were able to normalize blood glucose levels in streptozotocin diabetic NOD/SCID mice. In conclusion, reprogramming of human exocrine-enriched tissue can be best achieved using fresh material under conditions whereby EMT is inhibited, rather than allowing the culture to expand as a mesenchymal monolayer.",
keywords = "islet transplantation, stem cells, pancreatic transcription factors, gene therapy",
author = "Lima, {Maria Joao} and Muir, {Kenneth R.} and Docherty, {Hilary M.} and Robert Drummond and McGowan, {Neil W.A.} and Yves Heremans and Shareen Forbes and Isabelle Houbracken and Ross, {James A.} and Forbes, {Stuart J.} and Philippe Ravassard and Harry Heimberg and John Casey and Kevin Docherty",
year = "2013",
month = "8",
doi = "10.2337/db12-1256",
language = "English",
volume = "62",
pages = "2821--2833",
journal = "Diabetes",
issn = "0012-1797",
publisher = "AMER DIABETES ASSOC",
number = "8",

}

TY - JOUR

T1 - Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing β-like cells

AU - Lima, Maria Joao

AU - Muir, Kenneth R.

AU - Docherty, Hilary M.

AU - Drummond, Robert

AU - McGowan, Neil W.A.

AU - Heremans, Yves

AU - Forbes, Shareen

AU - Houbracken, Isabelle

AU - Ross, James A.

AU - Forbes, Stuart J.

AU - Ravassard, Philippe

AU - Heimberg, Harry

AU - Casey, John

AU - Docherty, Kevin

PY - 2013/8

Y1 - 2013/8

N2 - Because of the lack of tissue available for islet transplantation, new sources of β-cells have been sought for the treatment of type 1 diabetes. The aim of this study was to determine whether the human exocrine-enriched fraction from the islet isolation procedure could be reprogrammed to provide additional islet tissue for transplantation. The exocrine-enriched cells rapidly dedifferentiated in culture and grew as a mesenchymal monolayer. Genetic lineage tracing confirmed that these mesenchymal cells arose, in part, through a process of epithelial-to-mesenchymal transitioning (EMT). A protocol was developed whereby transduction of these mesenchymal cells with adenoviruses containing Pdx1, Ngn3, MafA, and Pax4 generated a population of cells that were enriched in glucagon-secreting α-like cells. Transdifferentiation or reprogramming toward insulin-secreting β-cells was enhanced, however, when using unpassaged cells in combination with inhibition of EMT by inclusion of Rho-associated kinase (ROCK) and transforming growth factor-β1 inhibitors. Resultant cells were able to secrete insulin in response to glucose and on transplantation were able to normalize blood glucose levels in streptozotocin diabetic NOD/SCID mice. In conclusion, reprogramming of human exocrine-enriched tissue can be best achieved using fresh material under conditions whereby EMT is inhibited, rather than allowing the culture to expand as a mesenchymal monolayer.

AB - Because of the lack of tissue available for islet transplantation, new sources of β-cells have been sought for the treatment of type 1 diabetes. The aim of this study was to determine whether the human exocrine-enriched fraction from the islet isolation procedure could be reprogrammed to provide additional islet tissue for transplantation. The exocrine-enriched cells rapidly dedifferentiated in culture and grew as a mesenchymal monolayer. Genetic lineage tracing confirmed that these mesenchymal cells arose, in part, through a process of epithelial-to-mesenchymal transitioning (EMT). A protocol was developed whereby transduction of these mesenchymal cells with adenoviruses containing Pdx1, Ngn3, MafA, and Pax4 generated a population of cells that were enriched in glucagon-secreting α-like cells. Transdifferentiation or reprogramming toward insulin-secreting β-cells was enhanced, however, when using unpassaged cells in combination with inhibition of EMT by inclusion of Rho-associated kinase (ROCK) and transforming growth factor-β1 inhibitors. Resultant cells were able to secrete insulin in response to glucose and on transplantation were able to normalize blood glucose levels in streptozotocin diabetic NOD/SCID mice. In conclusion, reprogramming of human exocrine-enriched tissue can be best achieved using fresh material under conditions whereby EMT is inhibited, rather than allowing the culture to expand as a mesenchymal monolayer.

KW - islet transplantation

KW - stem cells

KW - pancreatic transcription factors

KW - gene therapy

U2 - 10.2337/db12-1256

DO - 10.2337/db12-1256

M3 - Article

VL - 62

SP - 2821

EP - 2833

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 8

ER -